| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 411,865 | 408,591 | 407,940 | 396,753 | | Cost of Revenue | 188,223 | 179,693 | 184,621 | 191,392 | | | Gross Profit | 223,642 | 228,898 | 223,319 | 205,361 | | | Operating Expenses | | Research Development | 29,349 | 29,123 | 25,203 | 26,003 | | Selling General and Administrative | 131,153 | 130,749 | 126,788 | 132,769 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 63,140 | 69,026 | 71,328 | 46,589 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 171 | 176 | 8,784 | 354 | | Earnings Before Interest And Taxes | 63,311 | 69,202 | 80,112 | 46,943 | | Interest Expense | 14,549 | 14,477 | 14,609 | 12,783 | | Income Before Tax | 48,762 | 54,725 | 65,503 | 34,160 | | Income Tax Expense | 8,562 | 13,119 | 11,949 | 163 | | Minority Interest | (2,279) |
-
|
-
| (726) | | | | Net Income From Continuing Ops | 37,921 | 41,606 | 53,554 | 33,271 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 37,921 | 41,606 | 53,554 | 33,271 | | Preferred Stock And Other Adjustments | 1,741 | (1,212) | (529) |
-
| | | Net Income Applicable To Common Shares | $39,662 | $40,394 | $53,025 | $33,271 |
|
1.48% Nasdaq 
Income Statement
